Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba-MG 38025-180, Brazil.
Institute of Health Sciences, Federal University of Triângulo Mineiro, Uberaba-MG 38025-180, Brazil.
Biosensors (Basel). 2020 Jul 23;10(8):81. doi: 10.3390/bios10080081.
Visceral leishmaniasis is a reemerging neglected tropical disease with limitations for its diagnosis, including low concentration of antibodies in the serum of asymptomatic patients and cross-reactions. In this context, this work proposes an electrochemical immunosensor for the diagnosis of visceral leishmaniasis in a more sensitive way that is capable of avoiding cross-reaction with Chagas disease (CD). Crude antigens tested in the enzyme-linked immunosorbent assay (ELISA) were methodologically standardized to best engage to the sensor. The antibodies anti- and anti- sp. Present in serum from patients with diverse types of CD or leishmaniasis were chosen. A screen-printed carbon electrode modified with gold nanoparticles was the best platform to guarantee effective adsorption of all antigens so that the epitope of specific recognition for leishmaniasis occurred efficiently and without cross-reaction with the evaluated CD. The current peaks reduced linearly after the recognition, and still were able to notice the discrimination between different kinds of diseases (digestive, cardiac, undetermined Chagas/acute and visceral chronic leishmaniasis). Comparative analyses with ELISA were performed with the same groups, and a low specificity (44%) was verified due to cross-reactions (high number of false positives) on ELISA tests, while the proposed immunosensor presented high selectivity and specificity (100%) without any false positives or false negatives for the serum samples from isolated patients with different types of CD and visceral leishmaniasis. Furthermore, the biosensor was stable for 5 days and presented a detection limit of 200 ng mL.
内脏利什曼病是一种重新出现的被忽视的热带病,其诊断存在局限性,包括无症状患者血清中抗体浓度低和交叉反应。在这种情况下,这项工作提出了一种电化学免疫传感器,以更敏感的方式诊断内脏利什曼病,能够避免与恰加斯病(CD)的交叉反应。在酶联免疫吸附试验(ELISA)中测试的粗抗原经过方法学标准化,以最好地与传感器结合。选择了存在于不同类型 CD 或利什曼病患者血清中的抗和抗 sp. 抗体。用金纳米粒子修饰的丝网印刷碳电极是最佳平台,可确保所有抗原的有效吸附,从而有效地发生针对利什曼病的特异性识别表位,而不会与评估的 CD 发生交叉反应。识别后电流峰值线性降低,仍能够注意到不同疾病(消化、心脏、未确定的恰加斯/急性和内脏慢性利什曼病)之间的区分。与 ELISA 进行了相同组的比较分析,由于 ELISA 测试中的交叉反应(大量假阳性),特异性(44%)较低,而所提出的免疫传感器具有高选择性和特异性(100%),对于来自不同类型 CD 和内脏利什曼病的孤立患者的血清样本没有任何假阳性或假阴性。此外,该生物传感器在 5 天内保持稳定,检测限为 200ng/mL。